Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study (Blood Cancer Journal, (2020), 10, 7, (77), 10.1038/s41408-020-00342-x)

Authors :: Locatelli, Franco
Zugmaier, G.
Mergen, N.
Bader, P.
Jeha, S.
Schlegel, P. -G.
Bourquin, J. -P.
Handgretinger, R.
Brethon, B.
Rossig, C.
Chen-Santel, C.
Publication Year :: 2021
Publisher :: Springer Nature, 2021.

Subjects :: Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA
blinatumomab

Tools